These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16941463)

  • 1. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism.
    Gaig C; Martí MJ; Tolosa E; Valldeoriola F; Paredes P; Lomeña FJ; Nakamae F
    Mov Disord; 2006 Nov; 21(11):1994-8. PubMed ID: 16941463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
    Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
    J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.
    Catafau AM; Tolosa E;
    Mov Disord; 2004 Oct; 19(10):1175-82. PubMed ID: 15390019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of combining
    Niimi Y; Ito S; Murate K; Hirota S; Hikichi C; Ishikawa T; Maeda T; Nagao R; Shima S; Mizutani Y; Ueda A; Mutoh T
    J Neurol Sci; 2017 Jun; 377():174-178. PubMed ID: 28477690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.
    Nuvoli S; Spanu A; Piras MR; Nieddu A; Mulas A; Rocchitta G; Galleri G; Serra PA; Madeddu G
    Medicine (Baltimore); 2017 May; 96(21):e6967. PubMed ID: 28538394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degenerative parkinsonism in patients with psychogenic parkinsonism: A dopamine transporter imaging study.
    Felicio AC; Godeiro-Junior C; Moriyama TS; Shih MC; Hoexter MQ; Borges V; Silva SM; Aguiar Pde C; Andrade LA; Bressan RA; Ferraz HB
    Clin Neurol Neurosurg; 2010 May; 112(4):282-5. PubMed ID: 20061077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.
    Bairactaris C; Demakopoulos N; Tripsianis G; Sioka C; Farmakiotis D; Vadikolias K; Heliopoulos I; Georgoulias P; Tsougos I; Papanastasiou I; Piperidou C
    J Clin Neurosci; 2009 Feb; 16(2):246-52. PubMed ID: 19097795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
    Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I
    Quintas S; Sanles-Falagan R; Berbís MÁ
    Mov Disord Clin Pract; 2024 Jun; 11(6):613-625. PubMed ID: 38693679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
    Cummings JL; Fine MJ; Grachev ID; Jarecke CR; Johnson MK; Kuo PH; Schaecher KL; Oberdorf JA; Rezak M; Riley DE; Truong D
    Am J Manag Care; 2014 Mar; 20(5 Suppl):S97-109. PubMed ID: 24773455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.
    Akdemir ÜÖ; Bora Tokçaer A; Atay LÖ
    Turk J Med Sci; 2021 Apr; 51(2):400-410. PubMed ID: 33237660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders.
    Bártová P; Kraft O; Bernátek J; Havel M; Ressner P; Langová K; Herzig R; Skoloudík D
    Ultrasound Med Biol; 2014 Oct; 40(10):2365-71. PubMed ID: 25194454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism.
    Varrone A; Salvatore E; De Michele G; Barone P; Sansone V; Pellecchia MT; Castaldo I; Coppola G; Brunetti A; Salvatore M; Pappatà S; Filla A
    Ann Neurol; 2004 Mar; 55(3):426-30. PubMed ID: 14991822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The usefulness of SPECT with 123I-ioflupane (DaTSCAN) in Parkinsonism induced by pharmaceuticals].
    Duran-Ferreras E; Duran-Ferreras A
    Rev Neurol; 2011 Mar; 52(6):382-3. PubMed ID: 21387256
    [No Abstract]   [Full Text] [Related]  

  • 16. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the Diagnosis of Parkinsonian Syndromes With
    Banks KP; Peacock JG; Clemenshaw MN; Kuo PH
    AJR Am J Roentgenol; 2019 Aug; 213(2):243-253. PubMed ID: 30995085
    [No Abstract]   [Full Text] [Related]  

  • 18. DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism.
    Miyaue N; Tada S; Ando R; Iwaki H; Yabe H; Nishikawa N; Nagai M; Takashima H; Nomoto M
    Parkinsonism Relat Disord; 2017 Nov; 44():137-141. PubMed ID: 28844804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.
    Tolosa E; Borght TV; Moreno E;
    Mov Disord; 2007 Dec; 22(16):2346-51. PubMed ID: 17914722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dopamine transporter imaging in routine clinical practice.
    Marshall V; Grosset D
    Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.